Molecular Insights and Therapeutic Implications of Nanoengineered Dietary Polyphenols for Targeting Lung Carcinoma: Part I

References

• Jemal A , SiegelR, WardEet al. Cancer statistics, 2008. CA Cancer J. Clin.58(2), 71–96 (2008).
   PubMed Web of Science ®Google Scholar
• Ferlay J , SoerjomataramI, DikshitRet al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int. J. Cancer136(5), E359–386 (2015).
   PubMed Web of Science ®Google Scholar
• Hanahan D , WeinbergRA. Hallmarks of cancer: the next generation. Cell144(5), 646–674 (2011).
   PubMed Web of Science ®Google Scholar
• Herbst RS , HeymachJV, LippmanSM. Lung cancer. N. Engl. J. Med.359(13), 1367–1380 (2008).
   PubMed Web of Science ®Google Scholar
• Greenlee RT , MurrayT, BoldenS, WingoPA. Cancer statistics, 2000. CA Cancer J. Clin.50(1), 7–33 (2000).
   PubMed Web of Science ®Google Scholar
• Das SS , SinghSK, VermaP, JhaNK, GuptaPK, DuaK. Mitigating inflammation using advanced drug delivery by targeting TNF-alpha in lung diseases. Future Med. Chem.14(2), 57–60 (2021).
   PubMed Web of Science ®Google Scholar
• Yakut T , SchultenHJ, DemirAet al. Assessment of molecular events in squamous and non-squamous cell lung carcinoma. Lung Cancer54(3), 293–301 (2006).
   PubMed Web of Science ®Google Scholar
• Pesch B , KendziaB, GustavssonPet al. Cigarette smoking and lung cancer – relative risk estimates for the major histological types from a pooled analysis of case–control studies. Int. J. Cancer131(5), 1210–1219 (2012).
   PubMed Web of Science ®Google Scholar
• Brenner DR , BoffettaP, DuellEJet al. Previous lung diseases and lung cancer risk: a pooled analysis from the International Lung Cancer Consortium. Am. J. Epidemiol.176(7), 573–585 (2012).
   PubMed Web of Science ®Google Scholar
• Field RW , WithersBL. Occupational and environmental causes of lung cancer. Clin. Chest Med.33(4), 681–703 (2012).
   PubMed Web of Science ®Google Scholar
• Taylor R , NajafiF, DobsonA. Meta-analysis of studies of passive smoking and lung cancer: effects of study type and continent. Int. J. Epidemiol.36(5), 1048–1059 (2007).
   PubMed Web of Science ®Google Scholar
• WHO . Diet, nutrition and the prevention of chronic diseases: report of a joint WHO/FAO expert consultation. In: Technical Report Series. World Health Organization.Geneva, Switzerland (2003).
   Google Scholar
• Anand P , KunnumakkaraAB, SundaramCet al. Cancer is a preventable disease that requires major lifestyle changes. Pharm. Res.25(9), 2097–2116 (2008).
   PubMed Web of Science ®Google Scholar
• Bettio D , VenciA, AchilleV, AlloisioM, SantoroA. Lung cancer in which the hypothesis of multi-step progression is confirmed by array-CGH results: a case report. Exp. Ther. Med.11(1), 98–100 (2016).
   PubMed Web of Science ®Google Scholar
• Blanco D , VicentS, FragaMFet al. Molecular analysis of a multistep lung cancer model induced by chronic inflammation reveals epigenetic regulation of p16 and activation of the DNA damage response pathway. Neoplasia9(10), 840–852 (2007).
   PubMed Web of Science ®Google Scholar
• Zhou Q , PanH, LiJ. Molecular insights into potential contributions of natural polyphenols to lung cancer treatment. Cancers (Basel)11(10), 1565 (2019).
   PubMed Web of Science ®Google Scholar
• Hilbe W , ManegoldC, PircherA. Targeting angiogenesis in lung cancer – pitfalls in drug development. Transl. Lung Cancer Res.1(2), 122–128 (2012).
   PubMedGoogle Scholar
• McClelland MR , CarskadonSL, ZhaoLet al. Diversity of the angiogenic phenotype in non-small-cell lung cancer. Am. J. Respir. Cell Mol. Biol.36(3), 343–350 (2007).
   PubMed Web of Science ®Google Scholar
• Lambert AW , WongCK, OzturkSet al. Tumor cell-derived periostin regulates cytokines that maintain breast cancer stem cells. Mol. Cancer Res.14(1), 103–113 (2016).
   PubMed Web of Science ®Google Scholar
• Popper HH . Progression and metastasis of lung cancer. Cancer Metastasis Rev.35(1), 75–91 (2016).
   PubMed Web of Science ®Google Scholar
• Das SS , AlkahtaniS, BharadwajPet al. Molecular insights and novel approaches for targeting tumor metastasis. Int. J. Pharm.585, 119556 (2020).
   PubMed Web of Science ®Google Scholar
• Das SS , VermaPRP, KarS, SinghSK. Quercetin-loaded nanomedicine as oncotherapy. In: Nanomedicine for Bioactives.RahmanM, BegS, KumarV, AhmadF ( Eds). Springer Nature, Gateway East Singapore, Singapore, 155–183 (2020).
   Google Scholar
• Barkat HA , DasSS, BarkatMA, BegS, HadiHA. Selective targeting of cancer signaling pathways with nanomedicines: challenges and progress. Future Oncol.16(35), 2959–2979 (2020).
   PubMed Web of Science ®Google Scholar
• Buchner FL , Bueno-de-MesquitaHB, LinseisenJet al. Fruits and vegetables consumption and the risk of histological subtypes of lung cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC). Cancer Causes Control21(3), 357–371 (2010).
   PubMed Web of Science ®Google Scholar
• Das SS , VermaPRP, SinghSK. Quercetin-loaded nanomedicine as nutritional application. In: Nanomedicine for Bioactives.RahmanM, BegS, KumarV, AhmadF ( Eds). Springer Nature, Gateway East Singapore, Singapore, 259–301 (2020).
   Google Scholar
• Suvarna V , ChaubeyP, SangavePC, SinghAK. An insight of polyphenols in lung cancer chemoprevention. In: Polyphenols: Prevention and Treatment of Human Disease (2nd Edition).WatsonRR, PreedyVR, ZibadiS ( Eds). Academic Press, Washington, DC, USA, 125–136 (2018).
   Google Scholar
• Barkat HA , BarkatMA, TaleuzzamanM, DasSS, RizwanullahM, HadiHA. Receptor-based combinatorial nanomedicines. In: Handbook of Research on Advancements in Cancer Therapeutics.KumarS, RizviMA, VermaS ( Eds). IGI Global, PA, USA, 339–355 (2021).
   Google Scholar
• Christensen KY , NaiduA, ParentMEet al. The risk of lung cancer related to dietary intake of flavonoids. Nutr. Cancer64(7), 964–974 (2012).
   PubMed Web of Science ®Google Scholar
• Das SS , HussainA, VermaPRPet al. Recent advances in liposomal drug delivery system of quercetin for cancer targeting: a mechanistic approach. Curr. Drug Deliv.17(10), 845–860 (2020).
   PubMed Web of Science ®Google Scholar
• Grosso G , GodosJ, Lamuela-RaventosRet al. A comprehensive meta-analysis on dietary flavonoid and lignan intake and cancer risk: level of evidence and limitations. Mol. Nutr. Food Res.61(4), 10.1002/mnfr.201600930 (2017).
   PubMed Web of Science ®Google Scholar
• Zhang I , ZaorskyNG, PalmerJD, MehraR, LuB. Targeting brain metastases in ALK-rearranged non-small-cell lung cancer. Lancet Oncol.16(13), e510–e521 (2015).
   PubMed Web of Science ®Google Scholar
• Wegener G . Let food be thy medicine, and medicine be thy food: Hippocrates revisited. Acta Neuropsychiatr.26(1), 1–3 (2014).
   PubMed Web of Science ®Google Scholar
• Valdés L , CuervoA, SalazarN, Ruas-MadiedoP, GueimondeM, GonzálezS. The relationship between phenolic compounds from diet and microbiota: impact on human health. Food Funct.6(8), 2424–2439 (2015).
   PubMed Web of Science ®Google Scholar
• Yue W , MingQL, LinBet al. Medicinal plant cell suspension cultures: pharmaceutical applications and high-yielding strategies for the desired secondary metabolites. Crit. Rev. Biotechnol.36(2), 215–232 (2016).
   PubMed Web of Science ®Google Scholar
• Farzaei M , RahimiR, AbdollahiM. The role of dietary polyphenols in the management of inflammatory bowel disease. Curr. Pharm. Biotechnol.16(3), 196–210 (2015).
   PubMed Web of Science ®Google Scholar
• Rasouli H , FarzaeiMH, MansouriK, MohammadzadehS, KhodarahmiR. Plant cell cancer: may natural phenolic compounds prevent onset and development of plant cell malignancy? A literature review. Molecules21(9), 1104 (2016).
   PubMed Web of Science ®Google Scholar
• Amararathna M , JohnstonMR, RupasingheHPV. Plant polyphenols as chemopreventive agents for lung cancer. Int. J. Mol. Sci.17(8), 1352 (2016).
   PubMed Web of Science ®Google Scholar
• El Gharras H . Polyphenols: food sources, properties and applications – a review. Int. J. Food Sci. Technol.44(12), 2512–2518 (2009).
   Web of Science ®Google Scholar
• Manach C , ScalbertA, MorandC, RémésyC, JiménezL. Polyphenols: food sources and bioavailability. Am. J. Clin. Nutr.79(5), 727–747 (2004).
   PubMed Web of Science ®Google Scholar
• Maleki Dana P , SadoughiF, AsemiZ, YousefiB. The role of polyphenols in overcoming cancer drug resistance: a comprehensive review. Cell. Mol. Biol. Lett.27(1), 1 (2022).
   PubMed Web of Science ®Google Scholar
• Bhosale PB , HaSE, VetrivelP, KimHH, KimSM, KimGS. Functions of polyphenols and its anticancer properties in biomedical research: a narrative review. Transl. Cancer Res.9(12), 7619–7631 (2020).
   PubMed Web of Science ®Google Scholar
• Zamora-Ros R , RothwellJA, ScalbertAet al. Dietary intakes and food sources of phenolic acids in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Br. J. Nutr.110(8), 1500–1511 (2013).
   PubMed Web of Science ®Google Scholar
• D’Archivio M , FilesiC, DiBenedetto R, GargiuloR, GiovanniniC, MasellaR. Polyphenols, dietary sources and bioavailability. Annali-Istituto Superiore di Sanita.43(4), 348 (2007).
   PubMedGoogle Scholar
• Jakobek L , SerugaM, NovakI, Medvidovic-KosanovicM. Flavonols, phenolic acids and antioxidant activity of some red fruits. Deutsche Lebensmittel Rundschau103(8), 369–377 (2007).
   Web of Science ®Google Scholar
• Mattila P , PihlavaJ-M, HellströmJ. Contents of phenolic acids, alkyl- and alkenylresorcinols, and avenanthramides in commercial grain products. J. Agric. Food Chem.53(21), 8290–8295 (2005).
   PubMed Web of Science ®Google Scholar
• Chrzanowski G , LeszczynskiB, CzerniewiczP, SytykiewiczH, MatokH, KrzyzanowskiR. Phenolic acids of walnut (Juglans regia L.). Herba Polonica57(2), 22–29 (2011).
   Google Scholar
• Lafay S , Gil-IzquierdoA. Bioavailability of phenolic acids. Phytochem. Rev.7(2), 301–311 (2007).
   Google Scholar
• Russell W , DuthieG. Plant secondary metabolites and gut health: the case for phenolic acids. Proc. Nutr. Soc.70(3), 389–396 (2011).
   PubMed Web of Science ®Google Scholar
• Abotaleb M , LiskovaA, KubatkaP, BüsselbergD. Therapeutic potential of plant phenolic acids in the treatment of cancer. Biomolecules10, 221 (2020).
   PubMed Web of Science ®Google Scholar
• Lana R , SilvaNJA. Anticancer properties of phenolic acids in colon cancer – a review. J. Nutr. Food Sci.06(02), 10.4172/2155-9600.1000468 (2016).
   Google Scholar
• Srinivasulu C , RamgopalM, RamanjaneyuluG, AnuradhaCM, SureshKumar C. Syringic acid (SA) – a review of its occurrence, biosynthesis, pharmacological and industrial importance. Biomed. Pharmacother.108, 547–557 (2018).
   PubMed Web of Science ®Google Scholar
• Kang DY , NipinSP, JoESet al. The inhibitory mechanisms of tumor PD-L1 expression by natural bioactive gallic acid in non-small-cell lung cancer (NSCLC) cells. Cancers12(3), 727 (2020).
   PubMed Web of Science ®Google Scholar
• Kawada M , OhnoY, RiYet al. Anti-tumor effect of gallic acid on LL-2 lung cancer cells transplanted in mice. Anticancer Drugs12(10), 847–852 (2001).
   PubMed Web of Science ®Google Scholar
• Velli SK , SundaramJ, MuruganM, BalaramanG, ThiruvengadamD. Protective effect of vanillic acid against benzo(a)pyrene induced lung cancer in Swiss albino mice. J. Biochem. Mol. Toxicol.33(10), e22382 (2019).
   PubMed Web of Science ®Google Scholar
• Yin MC , LinCC, WuHC, TsaoSM, HsuCK. Apoptotic effects of protocatechuic acid in human breast, lung, liver, cervix, and prostate cancer cells: potential mechanisms of action. J. Agric. Food Chem.57(14), 6468–6473 (2009).
   PubMed Web of Science ®Google Scholar
• Tsao SM , HsiaTC, YinMC. Protocatechuic acid inhibits lung cancer cells by modulating FAK, MAPK, and NF-κB pathways. Nutr. Cancer66(8), 1331–1341 (2014).
   PubMed Web of Science ®Google Scholar
• Satoskar RR , ShahSJ, ShenoySG. Evaluation of anti-inflammatory property of curcumin (diferuloyl methane) in patients with postoperative inflammation. Int. J. Clin. Pharmacol. Ther. Toxicol.24(12), 651–654 (1986).
   PubMedGoogle Scholar
• Negi PS , JayaprakashaGK, JaganMohan Rao L, SakariahKK. Antibacterial activity of turmeric oil: a byproduct from curcumin manufacture. J. Agric. Food Chem.47(10), 4297–4300 (1999).
   PubMed Web of Science ®Google Scholar
• Mehta HJ , PatelV, SadikotRT. Curcumin and lung cancer – a review. Target. Oncol.9(4), 295–310 (2014).
   PubMed Web of Science ®Google Scholar
• Aggarwal BB , KumarA, BhartiAC. Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Res.23(1A), 363–398 (2003).
   PubMed Web of Science ®Google Scholar
• Tsai JR , LiuPL, ChenYHet al. Curcumin inhibits non-small-cell lung cancer cells metastasis through the adiponectin/NF-κB/MMPs signaling pathway. PLOS ONE10(12), e0144462 (2015).
   PubMed Web of Science ®Google Scholar
• Radhakrishna Pillai G , SrivastavaAS, HassaneinTI, ChauhanDP, CarrierE. Induction of apoptosis in human lung cancer cells by curcumin. Cancer Lett.208(2), 163–170 (2004).
   PubMed Web of Science ®Google Scholar
• Tang X , DingH, LiangMet al. Curcumin induces ferroptosis in non-small-cell lung cancer via activating autophagy. Thorac. Cancer12(8), 1219–1230 (2021).
   PubMed Web of Science ®Google Scholar
• Bourne LC , Rice-EvansC. Bioavailability of ferulic acid. Biochem. Biophys. Res. Commun.253(2), 222–227 (1998).
   PubMed Web of Science ®Google Scholar
• Bandugula VR , PrasadNR. 2-Deoxy-D-glucose and ferulic acid modulates radiation response signaling in non-small-cell lung cancer cells. Tumor Biol.34(1), 251–259 (2013).
   PubMed Web of Science ®Google Scholar
• Fong Y , TangCC, HuHTet al. Inhibitory effect of trans-ferulic acid on proliferation and migration of human lung cancer cells accompanied with increased endogenous reactive oxygen species and β-catenin instability. Chin. Med.11(1), 1–13 (2016).
   PubMedGoogle Scholar
• Jose Merlin JP , VenkadeshB, HussainR, RajanSS. Biochemical estimations of multidrug resistance (ferulic acid and paclitaxel) in non-small cells lung carcinoma cells in vitro. Biomed. Aging Pathol.3(2), 47–50 (2013).
   Google Scholar
• Ulasli SS , CelikS, GunayEet al. Anticancer effects of thymoquinone, caffeic acid phenethyl ester and resveratrol on A549 non-small-cell lung cancer cells exposed to benzo(a)pyrene. Asian Pac. J. Cancer Prev.14(10), 6159–6164 (2013).
   PubMedGoogle Scholar
• Lin CL , ChenRF, ChenJYet al. Protective effect of caffeic acid on paclitaxel induced anti-proliferation and apoptosis of lung cancer cells involves NF-κB pathway. Int. J. Mol. Sci.13(5), 6236–6245 (2012).
   PubMed Web of Science ®Google Scholar
• Klein-Júnior LC , CamposA, NieroR, CorrêaR, Vander HeydenY, FilhoVC. Xanthones and cancer: from natural sources to mechanisms of action. Chem. Biodivers.17(2), e1900499 (2020).
   PubMed Web of Science ®Google Scholar
• Singla RK , DubeyAK, GargAet al. Natural polyphenols: chemical classification, definition of classes, subcategories, and structures. J. AOAC Int. 102(5) 1397–1400 (2019).
   PubMed Web of Science ®Google Scholar
• Zhang C , YuG, ShenY. The naturally occurring xanthone α-mangostin induces ROS-mediated cytotoxicity in non-small scale lung cancer cells. Saudi J. Biol. Sci.25(6), 1090–1095 (2018).
   PubMed Web of Science ®Google Scholar
• De Filippis B , AmmazzalorsoA, FantacuzziM, GiampietroL, MaccalliniC, AmorosoR. Anticancer activity of stilbene-based derivatives. ChemMedChem12(8), 558–570 (2017).
   PubMed Web of Science ®Google Scholar
• Shen T , WangXN, LouHX. Natural stilbenes: an overview. Nat. Prod. Rep.26(7), 916–935 (2009).
   PubMed Web of Science ®Google Scholar
• Whyte L , HuangYY, TorresK, MehtaRG. Molecular mechanisms of resveratrol action in lung cancer cells using dual protein and microarray analyses. Cancer Res.67(24), 12007–12017 (2007).
   PubMed Web of Science ®Google Scholar
• Luo H , YangA, SchulteBA, WargovichMJ, WangGY. Resveratrol induces premature senescence in lung cancer cells via ROS-mediated DNA damage. PLOS ONE8(3), e60065–e60065 (2013).
   PubMed Web of Science ®Google Scholar
• Vinardell MP , MitjansM. Lignins and their derivatives with beneficial effects on human health. Int. J. Mol. Sci.18(6), 1219 (2017).
   PubMed Web of Science ®Google Scholar
• Xian H , FengW, ZhangJ. Schizandrin A enhances the efficacy of gefitinib by suppressing IKKβ/NF-κB signaling in non-small-cell lung cancer. Eur. J. Pharmacol.855, 10–19 (2019).
   PubMed Web of Science ®Google Scholar
• Rajasekar N , SivananthamA, RavikumarV, RajasekaranS. An overview on the role of plant-derived tannins for the treatment of lung cancer. Phytochemistry188, 112799–112799 (2021).
   PubMed Web of Science ®Google Scholar
• Sp N , KangDY, KimDHet al. Tannic acid inhibits non-small-cell lung cancer (NSCLC) stemness by inducing G0/G1 cell cycle arrest and intrinsic apoptosis. Anticancer Res.40(6), 3209–3220 (2020).
   PubMed Web of Science ®Google Scholar
• Pattarayan D , SivananthamA, KrishnaswamiVet al. Tannic acid attenuates TGF-β1-induced epithelial-to-mesenchymal transition by effectively intervening TGF-β signaling in lung epithelial cells. J. Cell. Physiol.233(3), 2513–2525 (2018).
   PubMed Web of Science ®Google Scholar
• Bharadwaj P , Das SS, Beg S, Rahman M. Formulation and biological stability of nanomedicines in cancer treatment. In: Nanoformulation Strategies for Cancer Treatment.BegS, RahmanM, ChoudhryH, SoutoEB, AhmadF ( Eds). Elsevier, Amsterdam, Netherlands, 277–289 (2021).
   Google Scholar
• Vasantha Rupasinghe HP , NairSVG, RobinsonRA. Chemopreventive Properties of Fruit Phenolic Compounds and Their Possible Mode of Actions.42, 229–266 (2014).
   Google Scholar
• Ferrazzano GF , AmatoI, IngenitoA, ZarrelliA, PintoG, PollioA. Plant polyphenols and their anti-cariogenic properties: a review. Molecules16(2), 1486–1507 (2011).
   PubMed Web of Science ®Google Scholar
• Tsao R . Chemistry and biochemistry of dietary polyphenols. Nutrients2(12), 1231–1246 (2010).
   PubMed Web of Science ®Google Scholar
• Mangal S , GaoW, LiT, ZhouQT. Pulmonary delivery of nanoparticle chemotherapy for the treatment of lung cancers: challenges and opportunities. Acta Pharmacol. Sin.38(6), 782–797 (2017).
   PubMed Web of Science ®Google Scholar
• Davatgaran-Taghipour Y , MasoomzadehS, FarzaeiMHet al. Polyphenol nanoformulations for cancer therapy: experimental evidence and clinical perspective. Int. J. Nanomed.12, 2689–2702 (2017).
   PubMed Web of Science ®Google Scholar
• Das SS , BharadwajP, BilalMet al. Stimuli-responsive polymeric nanocarriers for drug delivery, imaging, and theragnosis. Polymers (Basel)12(6), 1397 (2020).
   PubMed Web of Science ®Google Scholar
• Ernest U , ChenHY, XuMJet al. Anti-cancerous potential of polyphenol-loaded polymeric nanotherapeutics. Molecules23(11), 2787 (2018).
   PubMed Web of Science ®Google Scholar
• Kaminskas LM , McLeodVM, RyanGMet al. Pulmonary administration of a doxorubicin-conjugated dendrimer enhances drug exposure to lung metastases and improves cancer therapy. J. Control. Rel.183, 18–26 (2014).
   PubMed Web of Science ®Google Scholar
• Hafez IM , CullisPR. Roles of lipid polymorphism in intracellular delivery. Adv. Drug Deliv. Rev.47(2-3), 139–148 (2001).
   PubMed Web of Science ®Google Scholar
• Joshi N , ShirsathN, SinghA, JoshiKS, BanerjeeR. Endogenous lung surfactant inspired pH responsive nanovesicle aerosols: pulmonary compatible and site-specific drug delivery in lung metastases. Sci. Rep.4, 7085 (2014).
   PubMed Web of Science ®Google Scholar
• Zhu J , LiaoL, ZhuLet al. Size-dependent cellular uptake efficiency, mechanism, and cytotoxicity of silica nanoparticles toward HeLa cells. Talanta107, 408–415 (2013).
   PubMed Web of Science ®Google Scholar
• Maeda H . The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting. Adv. Enzyme Regul.41, 189–207 (2001).
   PubMedGoogle Scholar
• Markman JL , RekechenetskiyA, HollerE, LjubimovaJY. Nanomedicine therapeutic approaches to overcome cancer drug resistance. Adv. Drug Deliv. Rev.65(13-14), 1866–1879 (2013).
   PubMed Web of Science ®Google Scholar
• Garbuzenko OB , MainelisG, TaratulaO, MinkoT. Inhalation treatment of lung cancer: the influence of composition, size and shape of nanocarriers on their lung accumulation and retention. Cancer Biol. Med.11(1), 44–55 (2014).
   PubMedGoogle Scholar
• Komenek S , LuesakulU, EkgasitSet al. Nanogold–gallate chitosan-targeted pulmonary delivery for treatment of lung cancer. AAPS PharmSciTech18(4), 1104–1115 (2017).
   PubMed Web of Science ®Google Scholar
• Sunil Gowda SN , RajasowmiyaS, VadivelVet al. Gallic acid-coated sliver nanoparticle alters the expression of radiation-induced epithelial-mesenchymal transition in non-small lung cancer cells. Toxicol. In Vitro52, 170–177 (2018).
   PubMed Web of Science ®Google Scholar
• Rosman R , SaifullahB, ManiamS, DornianiD, HusseinMZ, FakuraziS. Improved anticancer effect of magnetite nanocomposite formulation of gallic acid (Fe3O4-PEG-GA) against lung, breast and colon cancer cells. Nanomaterials (Basel)8(2), 83 (2018).
   PubMedGoogle Scholar
• Gupta N , BhagatS, SinghMet al. Site-specific delivery of a natural chemotherapeutic agent to human lung cancer cells using biotinylated 2D rGO nanocarriers. Mater. Sci. Eng. C Mater. Biol. Appl.112, 110884 (2020).
   PubMed Web of Science ®Google Scholar
• Cordova CAS , LocatelliC, WinterEet al. Solid lipid nanoparticles improve octyl gallate antimetastatic activity and ameliorate its renal and hepatic toxic effects. Anticancer Drugs28(9), 977–988 (2017).
   PubMed Web of Science ®Google Scholar
• Huang X , TianX, ZhangQet al. Combined photothermal–immunotherapy via poly-tannic acid coated PLGA nanoparticles for cancer treatment. Biomater. Sci.9(18), 6282–6294 (2021).
   PubMed Web of Science ®Google Scholar
• Lee HY , JeongYI, KimEJet al. Preparation of caffeic acid phenethyl ester-incorporated nanoparticles and their biological activity. J. Pharm. Sci.104(1), 144–154 (2015).
   PubMed Web of Science ®Google Scholar
• Wang BL , ShenYM, ZhangQWet al. Codelivery of curcumin and doxorubicin by MPEG-PCL results in improved efficacy of systemically administered chemotherapy in mice with lung cancer. Int. J. Nanomed.8, 3521–3531 (2013).
   PubMedGoogle Scholar
• Yin H , ZhangH, LiuB. Superior anticancer efficacy of curcumin-loaded nanoparticles against lung cancer. Acta Biochim. Biophys. Sin. (Shanghai)45(8), 634–640 (2013).
   PubMed Web of Science ®Google Scholar
• Wang P , ZhangL, PengH, LiY, XiongJ, XuZ. The formulation and delivery of curcumin with solid lipid nanoparticles for the treatment of on non-small-cell lung cancer both in vitro and in vivo. Mater. Sci. Eng. C Mater. Biol. Appl.33(8), 4802–4808 (2013).
   PubMed Web of Science ®Google Scholar
• Sridhar R , RavananS, VenugopalJRet al. Curcumin- and natural extract-loaded nanofibres for potential treatment of lung and breast cancer: in vitro efficacy evaluation. J. Biomater. Sci. Polym. Ed.25(10), 985–998 (2014).
   PubMed Web of Science ®Google Scholar
• Teong B , LinCY, ChangSJet al. Enhanced anticancer activity by curcumin-loaded hydrogel nanoparticle derived aggregates on A549 lung adenocarcinoma cells. J. Mater. Sci. Mater. Med.26(1), 5357 (2015).
   PubMed Web of Science ®Google Scholar
• Gu Y , LiJ, LiYet al. Nanomicelles loaded with doxorubicin and curcumin for alleviating multidrug resistance in lung cancer. Int. J. Nanomed.11, 5757–5770 (2016).
   PubMed Web of Science ®Google Scholar
• Lee WH , LooCY, OngHX, TrainiD, YoungPM, RohanizadehR. Synthesis and characterization of inhalable flavonoid nanoparticle for lung cancer cell targeting. J. Biomed. Nanotechnol.12(2), 371–386 (2016).
   PubMed Web of Science ®Google Scholar
• Ranjan AP , MukerjeeA, GdowskiAet al. Curcumin–ER prolonged subcutaneous delivery for the treatment of non-small-cell lung cancer. J. Biomed. Nanotechnol.12(4), 679–688 (2016).
   PubMed Web of Science ®Google Scholar
• Zhu WT , LiuSY, WuLet al. Delivery of curcumin by directed self-assembled micelles enhances therapeutic treatment of non-small-cell lung cancer. Int. J. Nanomed.12, 2621–2634 (2017).
   PubMed Web of Science ®Google Scholar
• Luo CQ , XingL, CuiPFet al. Curcumin-coordinated nanoparticles with improved stability for reactive oxygen species-responsive drug delivery in lung cancer therapy. Int. J. Nanomed.12, 855–869 (2017).
   PubMed Web of Science ®Google Scholar
• Ibrahim S , TagamiT, KishiT, OzekiT. Curcumin marinosomes as promising nano-drug delivery system for lung cancer. Int. J. Pharm.540(1-2), 40–49 (2018).
   PubMed Web of Science ®Google Scholar
• Khan MN , HaggagYA, LaneME, McCarronPA, TambuwalaMM. Polymeric nano-encapsulation of curcumin enhances its anticancer activity in breast (MDA-MB231) and lung (A549) cancer cells through reduction in expression of HIF-1alpha and nuclear p65 (Rel A). Curr. Drug Deliv.15(2), 286–295 (2018).
   PubMed Web of Science ®Google Scholar
• Jiang K , ShenM, XuW. Arginine, glycine, aspartic acid peptide-modified paclitaxel and curcumin co-loaded liposome for the treatment of lung cancer: in vitro/vivo evaluation. Int. J. Nanomed.13, 2561–2569 (2018).
   PubMed Web of Science ®Google Scholar
• Hong Y , CheS, HuiB, WangX, ZhangX, MaH. Combination therapy of lung cancer using layer-by-layer cisplatin prodrug and curcumin co-encapsulated nanomedicine. Drug Des. Devel. Ther.14, 2263–2274 (2020).
   PubMed Web of Science ®Google Scholar
• Mardani R , HamblinMR, TaghizadehMet al. Nanomicellar-curcumin exerts its therapeutic effects via affecting angiogenesis, apoptosis, and T cells in a mouse model of melanoma lung metastasis. Pathol. Res. Pract.216(9), 153082 (2020).
   PubMed Web of Science ®Google Scholar
• Zhu X , YuZ, FengLet al. Chitosan-based nanoparticle co-delivery of docetaxel and curcumin ameliorates anti-tumor chemoimmunotherapy in lung cancer. Carbohydr. Polym.268, 118237 (2021).
   PubMed Web of Science ®Google Scholar
• Merlin JPJ , RajendraPrasad N, ShibliSMA, SebeelaM. Ferulic acid loaded Poly-d,l-lactide-co-glycolide nanoparticles: systematic study of particle size, drug encapsulation efficiency and anticancer effect in non-small-cell lung carcinoma cell line in vitro. Biomed. Preventive Nutr.2(1), 69–76 (2012).
   Google Scholar
• Hassanzadeh P , ArbabiE, RostamiF, AtyabiF, DinarvandR. Aerosol delivery of ferulic acid-loaded nanostructured lipid carriers: a promising treatment approach against the respiratory disorders. Physiol. Pharmacol.21(4), 331–342 (2017).
   Google Scholar
• Hu J , ChenLJ, LiuLet al. Liposomal honokiol, a potent anti-angiogenesis agent, in combination with radiotherapy produces a synergistic anti-tumor efficacy without increasing toxicity. Exp. Mol. Med.40(6), 617–628 (2008).
   PubMed Web of Science ®Google Scholar
• Wen J , FuAF, ChenLJet al. Liposomal honokiol inhibits VEGF-D-induced lymphangiogenesis and metastasis in xenograft tumor model. Int. J. Cancer124(11), 2709–2718 (2009).
   PubMed Web of Science ®Google Scholar
• Yang J , PeiH, LuoHet al. Non-toxic dose of liposomal honokiol suppresses metastasis of hepatocellular carcinoma through destabilizing EGFR and inhibiting the downstream pathways. Oncotarget8(1), 915–932 (2017).
   PubMedGoogle Scholar
• Yang J , WuW, WenJet al. Liposomal honokiol induced lysosomal degradation of Hsp90 client proteins and protective autophagy in both gefitinib-sensitive and gefitinib-resistant NSCLC cells. Biomaterials141, 188–198 (2017).
   PubMed Web of Science ®Google Scholar
• Ong CP , LeeWL, TangYQ, YapWH. Honokiol: a review of its anticancer potential and mechanisms. Cancers (Basel)12(1), 48 (2020).
   Web of Science ®Google Scholar
• Jiang QQ , FanLY, YangGLet al. Improved therapeutic effectiveness by combining liposomal honokiol with cisplatin in lung cancer model. BMC Cancer8, 242 (2008).
   PubMed Web of Science ®Google Scholar
• Li X , GuoQ, ZhengXet al. Preparation of honokiol-loaded chitosan microparticles via spray-drying method intended for pulmonary delivery. Drug Deliv.16(3), 160–166 (2009).
   PubMed Web of Science ®Google Scholar
• Gong C , WeiX, WangXet al. Biodegradable self-assembled PEG–PCL–PEG micelles for hydrophobic honokiol delivery: I. Preparation and characterization. Nanotechnology21(21), 215103 (2010).
   PubMed Web of Science ®Google Scholar
• Jin X , YangQ, CaiN, ZhangZ. A cocktail of betulinic acid, parthenolide, honokiol and ginsenoside Rh2 in liposome systems for lung cancer treatment. Nanomedicine (Lond.)15(1), 41–54 (2020).
   PubMed Web of Science ®Google Scholar
• Song Z , ShiY, HanQ, DaiG. Endothelial growth factor receptor-targeted and reactive oxygen species-responsive lung cancer therapy by docetaxel and resveratrol encapsulated lipid–polymer hybrid nanoparticles. Biomed. Pharmacother.105, 18–26 (2018).
   PubMed Web of Science ®Google Scholar
• Wang XX , LiYB, YaoHJet al. The use of mitochondrial targeting resveratrol liposomes modified with a dequalinium polyethylene glycol–distearoylphosphatidyl ethanolamine conjugate to induce apoptosis in resistant lung cancer cells. Biomaterials32(24), 5673–5687 (2011).
   PubMed Web of Science ®Google Scholar
• Karthikeyan S , RajendraPrasad N, GanamaniA, BalamuruganE. Anticancer activity of resveratrol-loaded gelatin nanoparticles on NCI-H460 non-small-cell lung cancer cells. Biomed. Preventive Nutr.3(1), 64–73 (2013).
   Google Scholar
• Karthikeyan S , HotiSL, PrasadNR. Resveratrol loaded gelatin nanoparticles synergistically inhibits cell cycle progression and constitutive NF-kappaB activation, and induces apoptosis in non-small-cell lung cancer cells. Biomed. Pharmacother.70, 274–282 (2015).
   PubMed Web of Science ®Google Scholar
• Kim JH , ParkEY, HaHKet al. Resveratrol-loaded nanoparticles induce antioxidant activity against oxidative stress. Asian-Australas. J. Anim. Sci.29(2), 288–298 (2016).
   PubMed Web of Science ®Google Scholar
• Zhao QS , HuLL, WangZD, LiZP, WangAW, LiuJ. Resveratrol-loaded folic acid-grafted dextran stearate submicron particles exhibits enhanced anti-tumor efficacy in non-small-cell lung cancers. Mater. Sci. Eng. C Mater. Biol. Appl.72, 185–191 (2017).
   PubMed Web of Science ®Google Scholar
• Abdelaziz HM , ElzoghbyAO, HelmyMW, SamahaMW, FangJY, FreagMS. Liquid crystalline assembly for potential combinatorial chemo-herbal drug delivery to lung cancer cells. Int. J. Nanomed.14, 499–517 (2019).
   PubMed Web of Science ®Google Scholar
• Abdelaziz HM , ElzoghbyAO, HelmyMWet al. Inhalable lactoferrin/chondroitin-functionalized monoolein nanocomposites for localized lung cancer targeting. ACS Biomater. Sci Eng.6(2), 1030–1042 (2020).
   PubMed Web of Science ®Google Scholar
• Zhang L , ZhuK, ZengHet al. Resveratrol solid lipid nanoparticles to trigger credible inhibition of doxorubicin cardiotoxicity. Int. J. Nanomed.14, 6061–6071 (2019).
   PubMed Web of Science ®Google Scholar